Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care

Elisabetta ChessaRheumatology Unit, University Clinic AOU of Cagliari, Cagliari, Italy

Matteo PigaRheumatology Unit, University Clinic AOU of Cagliari, Cagliari, ItalyCorrespondence[email protected]

Alberto FlorisRheumatology Unit, University Clinic AOU of Cagliari, Cagliari, Italy

Alessandro MathieuRheumatology Unit, University Clinic AOU of Cagliari, Cagliari, Italy

Alberto CauliRheumatology Unit, University Clinic AOU of Cagliari, Cagliari, Italy

Pages 167-170 | Published online: 11 Sep 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

No authors listedThe American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromesArthritis Rheum199942459960810211873
PubMed Web of Science ®Google Scholar
PigaMMathieuAManaging CNS involvement in systemic lupus erythematosusInt J Clin Rheumatol20116547567
Google Scholar
BortoluzziAScirèCABombardieriSDevelopment and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosusRheumatology (Oxford)201554589189825339643
PubMed Web of Science ®Google Scholar
PigaMCasulaLPerraDPopulation-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001–2012Lupus201625283726199283
PubMed Web of Science ®Google Scholar
HanlyJGUrowitzMBSuLShort-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort studyArthritis Rheum200859572172918438902
PubMed Web of Science ®Google Scholar
ZirkzeeEJHuizingaTWBollenELMortality in neuropsychiatric systemic lupus erythematosus (NPSLE)Lupus201423313824243776
PubMed Web of Science ®Google Scholar
PigaMChessaEPeltzMTFlorisAMathieuACauliADemyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysisAutoimmun Rev201716324425228159705
PubMed Web of Science ®Google Scholar
BertsiasGKIoannidisJPAringerMEULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsAnn Rheum Dis201069122074208220724309
PubMed Web of Science ®Google Scholar
EzeonyejiANIsenbergDAEarly treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimenRheumatology (Oxford)201251347648122096015
PubMed Web of Science ®Google Scholar
PepperRGriffithMKirwanCRituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroidsNephrol Dial Transplant200924123717372319617257
PubMed Web of Science ®Google Scholar
SteriMOrrùVIddaMLOverexpression of the cytokine BAFF and autoimmunity riskN Engl J Med2017376171615162628445677
PubMed Web of Science ®Google Scholar
Wahren-HerleniusMDörnerTImmunopathogenic mechanisms of systemic autoimmune diseaseLancet2013382989481983123993191
PubMed Web of Science ®Google Scholar
FlorisAPigaMCauliAMathieuAPredictors of flares in systemic lupus erythematosus: preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature reviewAutoimmun Rev201615765666326921641
PubMed Web of Science ®Google Scholar
PigaMGabbaACauliAGarauPVaccaAMathieuARituximab treatment for ‘rhupus syndrome’: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot studyLupus201322662462823559669
PubMed Web of Science ®Google Scholar
NarváezJRíos-RodriguezVde la FuenteDRituximab therapy in refractory neuropsychiatric lupus: current clinical evidenceSemin Arthritis Rheum20114136437221875742
PubMed Web of Science ®Google Scholar
TokunagaMSaitoKKawabataDEfficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous systemAnn Rheum Dis200766447047517107983
PubMed Web of Science ®Google Scholar
GladmanDDUrowitzBRahmanPIbañezDTamLSAccrual of organ damage over time in patients with systemic lupus erythematosusJ Rheumatol20033091955195912966597
PubMed Web of Science ®Google Scholar
PigaMPeltzMTMontaldoCTwenty-year brain magnetic resonance imaging follow-up study in systemic lupus erythematosus: factors associated with accrual of damage and central nervous system involvementAutoimmun Rev201514651051625617815
PubMed Web of Science ®Google Scholar
GovoniMBombardieriSBortoluzziAFactors and comorbidities associated with first central nervous system neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicenter retrospective cross sectional study on 959 Italian patientsRheumatology (Oxford)20125115716822075066
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date